Baseline plasma-informed circulating tumor DNA analyses comparing multiplex digital PCR and NGS for longitudinal monitoring in Hodgkin lymphoma.

Personalized blood tests track residual lymphoma without needing upfront tumor biopsy, enabling sensitive disease monitoring.

Baseline plasma-informed ctDNA approach comparing multiplex digital PCR and NGS shows comparable performance for longitudinal MRD monitoring in Hodgkin lymphoma, with personalized tumor-derived variants enabling highly sensitive disease tracking without upfront tumor tissue sequencing.

What the study was

Study design

prospective_cohort

Category

hematologic_malignancies

Maturity

translational

Journal

Blood Cancer Journal

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.